Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Kwality Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:539997NSE Symbol: Not ListedP/E(TTM):19.2
ISIN Demat:INE552U01010Div & Yield %:0EPS(TTM):47.31
Book Value(Rs):280.5612403Market Cap ( Cr.):942.37Face Value(Rs):10
    Change Company 
Date Headline
14-Nov-25 Kwality Pharmaceuticals consolidated net profit rises 66.71% in the September 2025 quarter
06-Nov-25 Kwality Pharmaceuticals to table results
11-Oct-25 Kwality Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
11-Sep-25 Kwality Pharmaceuticals Ltd - Shareholder Meeting / Postal Ballot-Scrutinizers Report
22-Aug-25 Kwality Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
19-Aug-25 Kwality Pharmaceuticals to conduct AGM
18-Aug-25 KPL receives nod to sell its anti-cancer drug Bleomycin 15 IU in Mexico
18-Aug-25 Kwality Pharma secures regulatory approval for anti-cancer drug Bleomycin in Mexico
16-Aug-25 Kwality Pharmaceuticals Ltd - Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM
16-Aug-25 Kwality Pharmaceuticals Ltd - 42Nd Annual General Meeting (AGM) Of The Shareholders Of The Company Will Be Held On Tues..
<< < 1 2 3 > >>